| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.45 | 0.003 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.36 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.03 |